Increased autocrine production of insulin-like growth factor II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation

Cell Proliferation

Volumn 29, Issue 9, 1996, Pages 479-493

  Corcoran, D ^a   Perachiotti, A ^a   Darbre, P D ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCARBONATE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; SERUM;

EID: 0030465598     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1996.tb00991.x     Document Type: Article

References (54)

1. AAKVAAG A, UTAAKER E, THORSEN T, LEA OA, LAHOOTI H. (1990) Growth control of human mammary cancer cells (MCF-7 cells) in culture: effects of estradiol and growth factors in serum-containing medium. Cancer Res. 50, 7806.
2. ALLEGRA JC, LIPPMAN ME. (1978) Growth of a human breast cancer cell line in serum-free hormone-supplemented medium. Cancer Res. 38, 3823.
3. BECK JS. (ed.) (1989) In: Oestrogen and the human breast. Proc. Roy. Soc. Edin. 95B, 1.
4. BELL GI, MERRYWEATHER JP, SANCHEZ-PESCADOR R et al. (1984) Sequence of a cDNA clone encoding human prepro insulin-like growth factor II. Nature 310, 775.
5. BERTHOIS Y, KATZENELLENBOGEN JA, KATZENELLENBOGEN BS. (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Nat. Acad. Sci. USA 83, 2496.
6. BRIAND P, LYKKESFELDT AE. (1984) Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. Cancer Res. 44, 1114.
7. BROWN AMC, JELTSCH JM, ROBERTS M, CHAMBON P. (1984) Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA 81, 6344.
8. CHO H, ARONICA SM, KATZENELLENBOGEN BS. (1994) Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-I, and serum factors. Endocrinology 134, 658.
9. CLARKE R, BRUNNER N, KATZ D et al. (1989) The effects of constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Mol. Endocrinol. 3, 372.
10. CONOVER CA. (1992) Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinol. 130, 3191.
11. CULLEN KJ, YEE D, SLY WS et al. (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 50, 48.
12. CULLEN KJ, LIPPMAN ME, CHOW D, HILL S, ROSEN N, ZWIEBEL JA. (1992) Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol. 6, 91.
13. DALY RJ, DARBRE PD. (1990) Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. Cancer Res. 50, 5868.
14. DALY RJ, HARRIS WH, WANG DY, DARBRE PD. (1991) Autocrine production of insulin-like growth factor II using an inducible expression system resulted in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Cell Growth Differentiation 2, 457.
15. DALY RJ, CARRICK N, DARBRE PD. (1995) Progression to steroid autonomy is accompanied by altered sensitivity to growth factors in S115 mouse mammary tumour cells. J. Steroid Biochem. Molec. Biol. 54, 21.
16. DARBRE P, YATES J, CURTIS S, KING RJD. (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43, 349.
17. DARBRE PD, CURTIS S, KING RJB. (1984) Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Cancer Res. 44, 2790.
18. DARBRE P, KING RJB. (1984) Progression to steroid autonomy in S115 mouse mammary tumour cells: role of DNA methylation. J. Cell Biol. 99, 1410.
19. DARBRE PD, DALY RJ. (1989) Effects of oestrogen on human breast cancer cells in culture. Proc. Roy. Soc. Edin. 95B, 119.
20. DARBRE PD, DALY RJ. (1990) Transition of human breast cancer cells from an oestrogen responsive to unresponsive state. J. Steroid Biochem. Molec. Biol. 37, 753.
21. DEVLEESCHOUWER N, OLEA-SERRANO N, LECLERCQ G, LEGROS N, HEUSON JC. (1986) Induction of progesterone receptor in an estrogen, progesterone receptor-negative breast cancer cell line. J. Steroid Biochem. 24, 365.
22. DICKSON RB, KASID A, HUFF KK et al. (1987) Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc. Natl. Acad. Sci. USA 84, 837.
23. ENGEL LW, YOUNG NA, TRALKA TS, LIPPMAN ME, O'BRIEN SJ, JOYCE MJ. (1978) Establishment and characterisation of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38, 3352.
24. FIGUEROA JA, YEE D. (1992) The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res. Treat. 22, 81.
25. FURUYA Y, KOHNO N, FUJIWARA Y, SAITOH Y. (1989) Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium. Cancer Res. 49, 6670.
26. GLOVER JF, IRWIN JT, DARBRE PD. (1988) Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D. Cancer Res. 48, 3693.
27. GOYA L, ALEXANDER DB, WEBSTER MK et al. (1993) Overexpression of transforming growth factor α overrides the glucocorticoid-mediated suppression of Con8 mammary tumour cell growth in vitro and in vivo. Cancer Res. 53, 1816.
28. HOSSENLOPP P, SEURIN D, QUINSON BS, HARDOUIN S, BINOUX M. (1986) Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154, 138.
29. HU T, BACH RR, HORTON R, KONIGSBERG WH, TODD MB. (1993) Synthesis of tissue factor messenger RNA and procoagulant activity in breast cancer cells in response to serum stimulation. Thromb. Res. 72, 155.
30. II DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. Science 228, 725.
31. KATZENELLENBOGEN BS, KENDRA KL, NORMAN MJ, BERTHOIS Y. (1987) Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 47, 4355.
32. KEYDAR I, CHEN L, KARBY S et al. (1979) Establishment and characterisation of a cell line of human breast carcinoma origin. Eur. J. Cancer 15, 659.
33. KRISHNAN AV, FELDMAN D. (1991) Stimulation of 1,25-dihydroxyvitamin D3 receptor gene expression in cultured cells by serum and growth factors. J. Bone Miner. Res. 6, 1099.
34. LEE AV, DARBRE P, KING RJB. (1994) Processing of insulin-like growth factor II (IGFII) by human breast cancer cells. Mol. Cell. Endocrinol. 99, 211.
35. LIPPMAN ME, DICKSON RB. (eds) (1990) Regulatory mechanisms in breast cancer: advances in cellular and molecular biology of breast cancer. Boston: Kluwer Academic Publishers.
36. LYKKESFELDT AE, LARSEN JK, CHRISTENSEN IJ, BRIAND P. (1986) Cell cycle analysis of estrogen stimulated growth of the human breast cancer cell line, MCF-7. Eur. J. Cancer Clin. Oncol. 22, 439.
37. MANIATIS T, FRITSCH EF, SAMBROOK J. (1982) Molecular cloning: a laboratory manual. New York: Cold Spring Harbor.
38. MCLESKEY SW, KUREBAYASHI J, HONIG SF et al. (1993) Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomised or tamoxifen-treated athymic nude mice. Cancer Res. 53, 2168.
39. MEDRANO EE, RESNICOFF M, CAFFERATA EG et al. (1990) Increased secretory activity and estradiol receptor expression are among other relevant aspects of MCF-7 human breast tumor cell growth which are expressed only in the absence of serum. Exp. Cell Res. 188, 2.
40. OSBORNE CK, HOBBS K, TRENT JM. (1987) Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat. 9, 111.
41. PAGE MJ, FIELD JK, EVERETT NP, GREEN CD. (1983) Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res. 43, 1244.
42. PERACHIOTTI A, DARBRE PD. (1994) Co-culture inserts possess an intrinsic ability to alter growth regulation of human breast cancer cells. Exp. Cell Res. 213, 404.
43. RUEDL C, CAPPELLETTI V, CORADINI D, GRANATA G, DIFRONZO G. (1990) Influence of culture conditions on the estrogenic cell growth simulation of human breast cancer cells. J. Steroid Biochem. Molec. Biol. 37, 195.
44. SALACINSKI PRP, MCLEAN C, SYKES JEC, CLEMENT-JONES VV, LOWRY PJ. (1981) Iodination of proteins, glycoproteins, and peptides using a solid phase oxidising agent, 1,3,4,6-tetrachloro-3,6-diphenyl glycouril (Iodogen). Anal. Biochem. 117, 136.
45. SALOMON DS, CIARDIELLO F, VALVERIUS EM, KIM N. (1990) The role of ras gene expression and transforming growth factor α production in the etiology and progression of rodent and human breast cancer. In: Lippman ME & Dickson RB eds. Regulatory Mechanisms in Breast Cancer: Advances in Cellular and Molecular Biology of Breast Cancer. Boston: Kluwer Academic Publishers, p. 107.
46. SHIMASAKI S, UCHIYAMA F, SHIMONAKA M, LING N. (1990) Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol. Endocrinol. 4, 1451.
47. II. Cancer Res. 50, 67.
48. SOTO AM, SONNENSCHEIN C. (1985) The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J. Steroid Biochem. 23, 87.
49. SOTO AM, SONNENSCHEIN C. (1987) Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocrine Reviews 8, 44.
50. STEWART AJ, JOHNSON MD, MAY FEB, WESTLEY BR. (1990) Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem. 265, 21 172.
51. STEWART HJ, ANDERSON TJ, FORREST APM. (eds) (1991) Breast cancer: new approaches. Brit. Med. Bull. 47 (2), 251.
52. SUKUMAR S, CARNEY WP, BARBACID M. (1988) Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas. Science 240, 524.
53. WEIJDE J, BLEGEN H, LARSSON O. (1992) Requirement for mevalonate in the control of proliferation of human breast cancer cells. Anticancer Res. 12, 317.
54. WIESE TE, KRAL LG, DENNIS KE, BUTLER WB, BROOKS SC. (1992) Optimization of estrogen growth response in MCF-7 cells. In Vitro Cell Dev. Biol. 28A, 595.